Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shoji Kajiura is active.

Publication


Featured researches published by Shoji Kajiura.


The Lancet | 1995

Preconceptional natural-killer-cell activity as a predictor of miscarriage

Koji Aoki; Shoji Kajiura; Yujin Matsumoto; Mayumi Ogasawara; Setsuo Okada; Yoshiaki Yagami; N. Gleicher

There is no immunological test for the prospective identification of alloimmune causes of miscarriage. We investigated whether activity of natural killer cells was predictive of subsequent abortion in women who had had unexplained recurrent abortions and had received no treatment. 24 women with high preconceptional NK activity, defined as mean plus 1 SD of NK activity of 47 controls, had a significantly higher abortion rate in the next pregnancy than 44 women with normal levels of NK activity (71 vs 20%; relative risk 3.5; 95% CI 1.8-6.5). The preconceptional evaluation of NK activity in women with recurrent miscarriages may thus be predictive of the risk of pregnancy loss at the next conception.


American Journal of Reproductive Immunology | 1997

Low Serum M-CSF Levels Are Associated with Unexplained Recurrent Abortion

Kinue Katano; Yujin Matsumoto; Mayumi Ogasawara; Tomomi Aoyama; Yasuhiko Ozaki; Shoji Kajiura; Koji Aoki

PROBLEM: The purpose of this study was to determine whether the serum macrophage‐colony stimulating factor (M‐CSF) level is associated with early pregnancy loss in unexplained recurrent spontaneous abortion (RSA) patients.


Fertility and Sterility | 1997

Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies

Mayumi Ogasawara; Shoji Kajiura; Kinue Katano; Tomomi Aoyama; Koji Aoki

OBJECTIVE To examine the predictive value of midluteal serum P as a marker of a luteal phase defect (LPD) in future pregnancies of recurrent aborters. DESIGN Prospective analysis. SETTING Nagoya City University Hospital. PATIENT(S) One hundred ninety-seven women with a history of two consecutive first trimester abortions, none of whom had any other medical problems or an identifiable cause of recurrent miscarriages, such as uterine anomalies or evidence of antiphospholipid antibodies. None of the study subjects received any medication for miscarriage or infertility. MAIN OUTCOME MEASURE(S) A midluteal phase single serum P level < 10 ng/mL was used as the criterion for a potential LPD: those whose subsequent pregnancy was successful and those in which failure was the end result. RESULT(S) Of the 197 patients, 46 (23.4%) demonstrated LPD without other endocrine abnormalities and 38 (19.3%) recurrent aborters suffered another abortion, with figures for LPD-negative and LPD-positive patients of 20.5% (31/151) and 15.2% (7/46), respectively. There was no statistically significant difference between the two groups. CONCLUSION(S) Progesterone, E2, and the P/E2 ratio may not predict future pregnancy loss in recurrent aborters.


American Journal of Reproductive Immunology | 1999

Prevalence of autoantibodies in patients with recurrent miscarriages.

Mayumi Ogasawara; Koji Aoki; Kinue Katano; Tomomi Aoyama; Shoji Kajiura; Kaoru Suzumori

PROBLEM: It is well known that the prevalence of several autoantibodies is higher in patients with recurrent miscarriages than in normal women. However, links between individual autoantibodies are unclear. The present study focuses on the possible association between β2‐glycoprotein I (β2‐GPI)‐dependant anticardiolipin antibody (aCL), lupus anticoagulant (LA), and antinuclear antibody (ANA) in patients with recurrent miscarriages.


Journal of Clinical Immunology | 1997

Clinical trial of immunostimulation with a biological response modifier in unexplained recurrent spontaneous abortion patients

Kinue Katano; Mayumi Ogasawara; Tomomi Aoyama; Yasuhiko Ozaki; Shoji Kajiura; Koji Aoki

We determined clinically whether a killed streptococcal preparation (KSP), a biological response modifier, is as effective as paternal lymphocyte immunotherapy for unexplained recurrent pregnancy abortion (RSA) therapy. The success rate of adverse pregnancy in the study group of 23 RSA cases, who were administered low doses of KSP before and during early pregnancy, was statistically compared with that in a control group of 205 women who received paternal lymphocyte immunotherapy. The association of natural killer (NK) cell activity in the peripheral blood with pregnancy outcome was also assessed. The success rate in the study group was 73.9% (17/23), compared to 75.1% (154/ 205) observed for the controls (not significant). Most of the successful cases exhibited low levels of NK cell activity in the peripheral blood. Immunotherapy with low doses of KSP is as effective as that with paternal lymphocytes, providing a simple and safe alternative therapy for unexplained RSA. Suppression of NK cell activity by some immunoregulatory mechanism was also found to have potential benefit in terms of a successful pregnancy outcome.


Prenatal Diagnosis | 1999

Biochemical examination of mother’s urine is useful for prenatal diagnosis of Bartter syndrome

Yuriko Matsushita; Yoshikatsu Suzuki; Naomi Oya; Shoji Kajiura; Kazuki Okajima; Osamu Uemura; Kaoru Suzumori

Bartter syndrome is characterized by renal potassium and chloride loss, hypokalaemia, hypochloraemic metabolic alkalosis and increased plasma renin activity along with elevated angiotensin II and hyperaldosteronism. For diagnosis we conducted biochemical examinations of both amniotic fluid and the mother’s urine. Except for potassium, amniotic fluid electrolytes in a mother with a fetus with Bartter syndrome were high. Urinary chloride, sodium and calcium were very low. Thus, the latter parameters may allow prediction of fetal Bartter syndrome during the prenatal period. Copyright


Pediatrics International | 1998

Prevalence of GBV‐C/HGV infection in pregnant Japanese women

Kohachiro Sugiyama; Kenji Goto; Yoshishige Miyake; Fumihiko Mizutani; Koji Terabe; Rou Li; Yoshiro Wada; Shoji Kajiura

Recently, a novel viral agent, hepatitis G virus, was identified by independent researchers from the serum of patients with liver disease, and termed GBV-C or HGV. At present, GBV-C and HGV are considered to be separate isolates of the same virus; however, the role of this virus in acute and chronic liver disease remains uncertain. Although vertical transmission is known to be one of the routes of transmission, the prevalence of GBV-C/HGV viremia in pregnant Japanese women is unknown. Thus, we determined this prevalence using the reverse transcription polymerase chain reaction (RT-PCR).


Acta Obstetricia et Gynecologica Scandinavica | 1995

A successful pregnancy in a woman with an elevated level of β2-glycoprotein I dependent anticardiolipin antibodies, despite a progressive thrombotic condition

Haruki Sasa; Koji Aoki; Mayumi Ogasawara; Shoji Kajiura; Yoshiaki Yagami

A number of investigators have shown that anticardiolipin antibodies (aCL) are associated with adverse pregnancy outcomes (1, 2). However, this issue is now controversial ( 3 ) and, moreover, possible mechanisms of pregnancy loss due to aCL remain unclear. Recently, it was reported that heterogeneity of aCL was defined by P,-glycoprotein I (P,GPI) dependency in binding of aCL to solid phase cardiolipin (4). It was additionally described that P2GPIdependent aCL had a potential prothrombotic action by attenuating the inhibitory effect of P2GPI ( 5 ) . In this clinical study, a P2GPI-dependent aCL positive pregnant woman was treated with a combination of prednisolone, aspirin, heparin, and immunoglobulin, and the effects on aCL levels, coagulating function and pregnancy outcome are evaluated.


International Journal of Gynecology & Obstetrics | 1994

Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters

Koji Aoki; Shoji Kajiura; Yujin Matsumoto; Yoshiaki Yagami

donor insemination treatment. Design: Prospective study. Setting: Jessop Hospital for Women, Sheffield. Subjects: Two groups: twenty-six infertile women and a control group of eight fertile women. Intervention: Endometrial biopsy specimens were obtained in the mid-luteal phase, timed precisely by the luteinising hormone surge. Main outcome measure: Morphological study of endometrial biopsy specimens by the use of traditional dating criteria and established morphometric techniques. Results: Twelve biopsy specimens (42%) were found to be retarded. In addition, morphometric analysis revealed significant differences in the glandular component of the endometrium between the infertile and fertile groups. Conclusion: Endometrial defect leading to implantation failure may be an important underlying cause of failure to conceive after repeated attempts at donor insemination. The endometrium should be investigated in this group of women, and further attempts at donor insemination treatment should be offered only in conjunction with attempts to restore the normality of the endometrium.


The Lancet | 1996

Are antinuclear antibodies predictive of recurrent miscarriage

Mayumi Ogasawara; Koji Aoki; Shoji Kajiura; Yoshiaki Yagami

Collaboration


Dive into the Shoji Kajiura's collaboration.

Top Co-Authors

Avatar

Koji Aoki

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Haruki Sasa

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. Kimbara

Nagoya City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge